Page 66 - Magyar Gasztroenterológiai Társaság 2020. november 6–7. – ONLINE KONGRESSZUS
P. 66

Előadáskivonatok / Abstracts


             Hospital,  Szombathely;  5.  1st  Dept.  of  Internal  Medicine,   CI95% 2.1-4.1; p<0.001), endoscopic intervention (OR 1.4,
             Petz  A  Teaching  Hospital,  Gyor;  6.  2nd  Dept.  of  Internal   CI95% 1.1-1.9; p=0.033), mortality (OR 9.0, CI95% 4.7-17.2;
             Medicine,  St.  Rafael  Teaching  Hospital,  Zalaegerszeg;  7.   p<0.001) and hospitalization length (p<0.001).
             Dept.  of  Gastroenterology,  St.  Pantaleon  Hospital,   Conclusion: Incidence rates of acute upper GI bleeding in
             Dunaujvaros;  8.  McGill  University  Health  Center,  Montreal   Western Hungary are in line with international trends. The
             General Hospital, Canada                         ASA-score,  GBS  and  RS  predicted  outcomes  and
                                                              transfusion  requirements.  We  observed  higher  mortality
             Introduction: Acute upper gastrointestinal (GI) bleeding is   rates,  which  can  partially  be  explained  by  the  high
             associated with significant morbidity and mortality.   comorbidity rates in this population, but warrant optimization
             Aims:  Our  aim  was  to  evaluate  characteristics  and   of the management of acute non-variceal upper GI bleeding.
             prognostic  factors  in  the  management  of  acute  upper  GI
             bleeding in a large multi-center study from Hungary.   84.   USE   OF   EVIDENCE-BASED   MANAGEMENT
             Methods: The present prospective one–year study involved   GUIDELINES  IMPROVE  THE  OUTCOME  OF  ACUTE
             six major community hospitals in Western Hungary covering   PEDIATRIC PANCREATITIS
                                                                                                 2,3
                                                                      1
             a population of 1,263,365 persons in 2016. Data collection   Lasztity  N. ,  Mosztbacher  D. 2,3,4 ,  Juhász  F. ,  Tokodi  I. ,
                                                                                                           5
                                                                             6
                                                                                       7
             included  demographic  characteristics,  vital  signs  at   Tészás A. , Vass I. , Gárdos L. , Szentesi A. 2,11 , Demcsák
                                                                      6
                                                                       8
                                                                                            9
                                                                              3
                                                                                                      9
             admission,  comorbidities,  medications,  time  to  hospital   A. , Tóth A. , Tél B. , Csoszánszki N. , Tomsits E. , Hegyi
                                                                8
             admission  and  endoscopy,  laboratory  results,  endoscopic   P. 2,10,11,12 , Párniczky A. 2,4,13
             management, including endoscopic therapy and second look   1. Szent János's Hospital and North Buda Unified Hospitals,
             endoscopy,  risk  assessment  using  Glasgow-Blatchford   Budapest;  2.  Institute  for  Translational  Medicine,  Medical
             Score (GBS), Rockall Score (RS) and the American Society   School,  University  of  Pécs,  Pécs;  3.  First  Department  of
             of  Anesthesiologists  (ASA)  Physical  Status  Score,   Pediatrics,  Semmelweis  University,  Budapest;  4.  Clinical
             transfusion  requirements,  length  of  hospital  stay  and   Medicine Doctoral School, University of Szeged, Szeged; 5.
             mortality.                                       St.  György  University  Teaching  Hospital  of  Fejér  County,
             Results:  688  cases  (incl.  117  in-hospital  cases)  of  acute   Székesfehérvár;  6.  Department  of  Pediatrics,  Medical
             upper non-variceal GI bleeding were registered in the 1-year   School, University of Pécs,; 7. Department of Pediatrics, Zala
             study period, resulting an estimated incidence rate of 54.42   County Hospital Szent Rafael, Zalaegerszeg; 8. Department
             (CI95%  50.5-58.6)  per  100,000  population  per  year  in   of  Pediatrics,  University  of  Szeged,  Szeged;  9.  Second
             Western Hungary. Time from symptom onset to presentation   Department of Pediatrics, Semmelweis University, Budapest;
             at the Emergency Department (ER) was <6 hours in 35.9%   10. Division of Translational Medicine, First Department of
             and  <12  hours  in  52.7%  of  the cases  (n=571).  Time  from   Medicine,  Medical  School,  University  of  Pécs;  11.  First
             hospitalization  to  endoscopy was  <  6  hours in  55.7% and   Department of Medicine, University of Szeged, Szeged; 12.
             <12h  in  71.8%  (n=678).  Top  5  diagnoses  were  duodenal   Hungarian  Academy  of  Sciences-University  of  Szeged,
             ulcer (20.6%), gastric ulcer (19.0%), gastroesophageal reflux   Momentum  Gastroenterology  Multidisciplinary  Research
             disease (GERD) (11.1%), erosive gastritis/duodenitis (9.9%)   Group; 13. Heim Pál National Insitute of Pediatric, Budapest
             and Mallory-Weiss syndrome (8.2%), while malignancy in the
             upper GI track and arteriovenous malformation (AVM) were   Introduction: The incidence of pediatric acute pancreatitis
             present in 4.0% and 3.8%. Forrest stage was Ia-b, IIA-b-c in   (APP) is rising and have a significant effect on the life of the
             7.1%, 17.6%, 15.7%, 13.0% and 13.6% of the cases (n=323).   children and parents. Pediatric pancreatitis (PP) requires up-
             Helicobcter pylori positivity was observed in 30.6% (71/232)   to-date  and  evidence-based  treatment  approaches.  The
             of  the  tested  cases.  Therapeutic  intervention  on  initial   EPC/HPSG evidence-based guidelines provides the current
             endoscopy was performed in 37.1%, while 35.9% of patients   state of the art of the diagnosis and management of PP.
             required second look endoscopy. Intravenous proton-pump   Aims:  The  aim  of  this  study  was  to  analyze  the  clinical
             inhibitor  (PPI)  was  the  initial  medical  therapy  in  78.8%  of   characteristics  of  APP  in  a  prospectively  collected,
             patients (16.4% received 72h iv PPI perfusor therapy). Blood   multicentric cohort and to compare the management to the
             transfusion  was  given  to  65.7%  of  the  patients.   major recommendations of the EPC/HPSG evidence-based
             Hospitalization stay exceeded 7 days in 50.3, while 5.3% of   guidelines for PP.
             the patients required surgical treatment. Mortality was 11.6%   Methods: Hungarian Pancreatic Study Group launched an
             among patients with bleeding episode presenting outside the   international,  multicentric,  observational  trial  (APPLE-
             hospital, while the overall mortality rate (including in-hospital   Analysis  of  Pediatric  Pancreatitis,  ISRCTN89664974)  with
             bleedings) was 13.5%. Longer time to presentation at the ER   the aim of collecting prospective clinical data and biological
             predicted  transfusion  requirements  (p=0.038),  while   samples  from  children  with  PP.46  children  suffering  from
             weekend  presentation  was  associated  with  transfusion   APP  have  been  enrolled  from  14  centers.  Conservative
             (p=0.047),  surgery  (p=0.016)  and  mortality  (p=0.021).   treatment of APP in the first 24-48 hours were analyzed on
             Presentation  with  vegetative  symptoms  at  admission  (i.e.   the  outcome  parameters  by  dividing  the  cohort  into  two
             tachycardia, hypotension or syncope) was associated with   groups. 1. guideline group: the EPC/HPSG evidence-based
             increased  transfusion  needs  (p<0.001),  longer  in-hospital   guidelines for PP served as a gold standard 2. non-guideline:
             stay  (p<0.001)  and  mortality  (p=0.017).  Patients  on   other, individual therapeutic strategy (mostly based on local
             anticoagulant,   antithrombotic   or   non-steroidal   anti-  experience) for the therapy of APP.
             inflammatory  drug  (NSAID)  medications  had  higher   Results:  In  the  first  24-48  hours  of  the  treatment  the
             transfusion  needs  (p<0.001)  and  longer  in-hospital  stay   guideline’s   recommended   intravenous   fluid   (IVF)
             (p=0.004), but no increased mortality (p=0.571). The GBS   replacement  (1.5-2  times  of  the  maintenance)  was
             was  predictive  of  transfusion  (AUC:  0.82;  cut-off:  GBS   administered  in  17/46(37%)  cases.  Majority  of  the
             >7points; sensitivity: 71.9% specificity: 78%), while mortality   patients(29/46, 63%) received the maintenance IVF or less.
             was strongly associated with the post-endoscopic RS (AUC:   There  was no significant difference in the severity of APP
             0.75;  cut-off:  RS  >5points;  sensitivity:  68.8%  specificity:   between the guideline and non-guideline groups(p=0.45). Nil
             68.9%). Presence of comorbidities and ASA stage correlated   per os diet was used in 18 patients(72.2%), while 20 patients
             with transfusion requirements (ASA 1-2 vs. ASA 3-4: OR 2.9,   with  mild  APP  were  fed  per  os.  Enteral  tube  feeding  was
             64


       64    Central European Journal of Gastroenterology and Hepatology
             Volume 6, Supplementum 2 / November 2020
   61   62   63   64   65   66   67   68   69   70   71